CD8A and neoplasm: In order to determine whether intratumoral vaccination with the E7 peptide in combination with PADRE peptide and poly(I:C) would generate enhanced E7-specific CD8+ T cell immune responses, C57BL/6 mice (5 per group) were challenged subcutaneously with TC-1 tumor cells in the right leg.